GR3029773T3 - Monoclonal antibodies to glycoprotein p. - Google Patents

Monoclonal antibodies to glycoprotein p.

Info

Publication number
GR3029773T3
GR3029773T3 GR990400860T GR990400860T GR3029773T3 GR 3029773 T3 GR3029773 T3 GR 3029773T3 GR 990400860 T GR990400860 T GR 990400860T GR 990400860 T GR990400860 T GR 990400860T GR 3029773 T3 GR3029773 T3 GR 3029773T3
Authority
GR
Greece
Prior art keywords
pct
glycoprotein
date dec
sec
monoclonal antibody
Prior art date
Application number
GR990400860T
Other languages
English (en)
Inventor
Maurizio Cianfriglia
Original Assignee
Ist Superiore Sanita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Superiore Sanita filed Critical Ist Superiore Sanita
Publication of GR3029773T3 publication Critical patent/GR3029773T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GR990400860T 1992-06-17 1999-03-23 Monoclonal antibodies to glycoprotein p. GR3029773T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM920457A IT1257893B (it) 1992-06-17 1992-06-17 Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana.
PCT/EP1993/001533 WO1993025700A1 (en) 1992-06-17 1993-06-16 Monoclonal antibodies to glycoprotein p

Publications (1)

Publication Number Publication Date
GR3029773T3 true GR3029773T3 (en) 1999-06-30

Family

ID=11401066

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990400860T GR3029773T3 (en) 1992-06-17 1999-03-23 Monoclonal antibodies to glycoprotein p.

Country Status (20)

Country Link
US (1) US5766946A (el)
EP (1) EP0648276B1 (el)
JP (1) JPH08501925A (el)
KR (1) KR100301189B1 (el)
AT (1) ATE174967T1 (el)
AU (1) AU672798B2 (el)
CA (1) CA2134752A1 (el)
CZ (1) CZ284847B6 (el)
DE (1) DE69322783T2 (el)
DK (1) DK0648276T3 (el)
ES (1) ES2130271T3 (el)
FI (1) FI945865A (el)
GR (1) GR3029773T3 (el)
HU (1) HU216877B (el)
IT (1) IT1257893B (el)
NO (1) NO944887L (el)
NZ (1) NZ253139A (el)
RU (1) RU2126836C1 (el)
SK (1) SK280272B6 (el)
WO (1) WO1993025700A1 (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994088A (en) * 1991-03-08 1999-11-30 Board Of Trustees Of The University Of Illinois Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
EP0669941A1 (en) * 1992-11-02 1995-09-06 NICOLAU, Yves Claude Method of reducing multidrug resistance in cells and tissues
US5686578A (en) 1994-08-05 1997-11-11 Immunomedics, Inc. Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
AU3482297A (en) * 1996-06-05 1998-01-05 Eugene Mechetner Reagents and methods for inhibiting cytokine release by blood cells
AU5799199A (en) * 1998-09-04 2000-03-27 Immunomedics Inc. Diagnosis of multidrug resistance in cancer and infectious lesions
WO2001055218A1 (en) * 2000-01-31 2001-08-02 The Procter & Gamble Company Antibodies to the staphylococcal multidrug resistance (smr) protein
EP3333182A1 (en) * 2000-06-05 2018-06-13 The Brigham and Women's Hospital, Inc. A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
EP1223534A1 (en) * 2001-01-14 2002-07-17 Katz, Emil Peptides representative of polypeptides of interest and antibodies directed thereagainst, and methods, systems and kits for generating and utilizing each
US8663650B2 (en) 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
US7294701B2 (en) * 2003-04-02 2007-11-13 Technion Research & Development Foundation Ltd. Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
US7807171B2 (en) 2003-07-25 2010-10-05 Ac Immune Sa Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
FR2857875A1 (fr) * 2003-07-25 2005-01-28 Univ Reims Champagne Ardenne Vaccin therapeutique cible contre la p-glycoproteine 170 pour inhiber la resistance multidrogues dans le traitement des cancers
US20060068426A1 (en) * 2004-08-20 2006-03-30 Tam James P Cyclic peptides and antibodies thereof
CA2685492C (en) 2006-05-31 2018-01-16 The Brigham And Women's Hospital, Inc. Abcb5 positive mesenchymal stem cells as immunomodulators
FR2906533B1 (fr) 2006-09-28 2013-02-22 Pf Medicament Procede de generation d'anticorps actifs contre un antigene de resistance,anticorps obtenus par ledit procede et leurs utilisations
DK2155248T3 (en) 2007-04-12 2015-09-14 Brigham & Womens Hospital Targeting abcb5 for cancer therapy
US9289488B2 (en) 2010-08-12 2016-03-22 Ac Immune Sa Vaccine engineering
EP2632434A1 (en) 2010-10-26 2013-09-04 AC Immune S.A. Liposome-based construct comprising a peptide modified through hydrophobic moieties

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206352A (en) * 1986-03-28 1993-04-27 Board Of Trustees Of The University Of Illinois Compositions for clones containing DNA sequences associated with multidrug resistance in human cells
US5434075A (en) * 1992-03-20 1995-07-18 Board Of Trustees Of The University Of Illinois Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
US5773280A (en) * 1992-03-20 1998-06-30 The Board Of Trustees Of The University Of Illinois Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
AU3691093A (en) * 1992-04-14 1993-10-21 Hybritech Incorporated Methods of inhibiting the growth of multidrug resistant tumors
US5369009A (en) * 1992-04-17 1994-11-29 Dana Farber Cancer Institute Antibodies for P-glycoprotein encoded by the mdr1 gene and uses thereof

Also Published As

Publication number Publication date
DE69322783T2 (de) 1999-06-10
FI945865A0 (fi) 1994-12-13
NO944887D0 (no) 1994-12-16
FI945865A (fi) 1995-02-08
DK0648276T3 (da) 1999-08-23
SK280272B6 (sk) 1999-10-08
CA2134752A1 (en) 1993-12-23
IT1257893B (it) 1996-02-16
NZ253139A (en) 1996-09-25
EP0648276B1 (en) 1998-12-23
HU9403614D0 (en) 1995-02-28
ES2130271T3 (es) 1999-07-01
WO1993025700A1 (en) 1993-12-23
ITRM920457A1 (it) 1993-12-17
HU216877B (hu) 1999-09-28
JPH08501925A (ja) 1996-03-05
EP0648276A1 (en) 1995-04-19
ATE174967T1 (de) 1999-01-15
HUT70469A (en) 1995-10-30
DE69322783D1 (de) 1999-02-04
RU2126836C1 (ru) 1999-02-27
SK155494A3 (en) 1995-07-11
NO944887L (no) 1994-12-16
AU4326693A (en) 1994-01-04
KR100301189B1 (ko) 2001-10-22
ITRM920457A0 (it) 1992-06-17
CZ284847B6 (cs) 1999-03-17
AU672798B2 (en) 1996-10-17
RU94046414A (ru) 1996-11-10
CZ318194A3 (en) 1995-07-12
US5766946A (en) 1998-06-16

Similar Documents

Publication Publication Date Title
HUT70469A (en) Monoclonal antibodies to glycoprotein p.
NO962346L (no) Humaniserte antistoffer og anvendelser derav
HK1012841A1 (en) Pharmaceutical composition for the treatment or prevention of amalignant tumor
GB9304979D0 (en) Imobilisation and separation of cells and other particles
RS51309B (sr) Humana monoklonalna antitela za ctla-4
CA2124126A1 (en) Monoclonal antibodies and fv specific for cd2 antigen
IL105541A0 (en) Monoclonal antibodies to gp130 protein,processes for the preparation thereof and pharmaceutical compositions containing the same
HUT76260A (en) Monoclonal antibody active against cd44v6
ATE146528T1 (de) Kleinzelliger lungenkarzinom-spezifischer antikörper und antigenen
Cline et al. Receptors for immunoglobulin on B lymphocytes and cells of a cultured plasma cell tumor
AU6832398A (en) Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
DE69629688D1 (de) Chemoattraktion-auslösender faktor aus lymphozyten und dessen verwendungen
FI932912A (fi) Testmetod och reagensfoerpackning avsedd foer den
DK0547200T3 (da) Rekombinante antistoffer på overfladen af E. coli
NO922621L (no) Farmasoeytiske preparater inneholdende antigen-antistoffkomplekser og anvendelser derav
CA2178635A1 (en) Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form
DE3580382D1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
CA2137280A1 (fr) Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications
SG48841A1 (en) 06-methylguanine-DNA-methyltransferase (MGMT) specific antibodies
ATE221388T1 (de) Zusammensetzungen die gemischte transferrine als wirkstoff für induktion von immunotoleranz gegen antigen enthalten
ATE122895T1 (de) Monoklonale antikörper gegen den interleukin 2- rezeptor.
CA2148689A1 (en) Treatment of infertility and enhancement of fertilization capacity in mammalian males
Boylston et al. Human T lymphocytes expressing a defined T-cell antigen receptor family specifically kill the hybridoma that makes the anti-receptor monoclonal antibody.
DE59611353D1 (de) Transketolase-verwandtes protein